What do studies say about Abnehmspritze Test?

The term 'Abnehmspritze Test' typically refers to genetic tests claiming to predict response to GLP-1 agonists (e.g., semaglutide, tirzepatide). Current evidence does not support the use of any single genetic variant to reliably predict weight loss outcomes with these drugs. While genes such as GLP1R, TCF7L2, and PPARG have been linked to weight regulation in GWAS, effect sizes are small and not clinically actionable. Consumer DNA tests marketed for this purpose often rely on weak or mechanistic evidence. GLP-1 agonists are prescription-only medications with significant side effects (nausea, pancreatitis, gallstones). A genetic test cannot replace medical evaluation. Evidence level: mixed – some biological plausibility exists, but no validated clinical test is available. Safety note: do not self-prescribe; medical supervision is mandatory.